New challenges for HIV testing in the setting of long-acting cabotegravir pre-exposure prophylaxis

dc.contributor.authorWilliams, E.
dc.contributor.authorChibo, D.
dc.contributor.authorD'Costa, J.
dc.contributor.authorNicholson, S.
dc.contributor.authorJackson, K.
dc.contributor.authorLim, C.K.
dc.contributor.authorWilliamson, D.A.
dc.date.issued2024
dc.descriptionCorrespondence
dc.description.statementofresponsibilityEloise Williams, Doris Chibo, Jodie D'Costa, Suellen Nicholson, Kathy Jackson, Chuan K. Lim, Deborah A. Williamson
dc.identifier.citationPathology, 2024; 57(1):105-107
dc.identifier.doi10.1016/j.pathol.2024.08.011
dc.identifier.issn0031-3025
dc.identifier.issn0031-3025
dc.identifier.urihttps://hdl.handle.net/2440/144571
dc.language.isoen
dc.publisherElsevier
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/GNT2005380
dc.rights© 2024 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
dc.source.urihttps://doi.org/10.1016/j.pathol.2024.08.011
dc.subjectlong-acting cabotegravir (CAB-LA); HIV pre-exposure prophylaxis (PrEP); Pharmaceutical Benefits Advisory Committee (PBAC)
dc.titleNew challenges for HIV testing in the setting of long-acting cabotegravir pre-exposure prophylaxis
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections